Eliminate Adverse Events with Integrated Clinical Pathways

Mark A. Snyder, MD, FAOA

The current healthcare environment is forcing hospitals to face uncertain futures and chart new courses as they shift from volume- to value-based systems and business models. According to Ian Morrison, author of The Second Curve: Managing the Velocity of Change, the second curve is the future—new technologies, new consumers, and new markets—and traditional methods of change are not sufficient to enable companies, including healthcare organizations, to survive.

Second Look – Clinical News and Views

These items originally appeared in AAOS Headline News Now, a thrice-weekly enewsletter that keeps AAOS members up to date on clinical, socioeconomic, and political issues, with links to more detailed information. Subscribe at www.aaos.org/news/news.asp (member login required).

Introducing the Starfish Procedure

R. Glenn Gaston, MD; Bryan J. Loeffler, MD

Significant advancements have been made in upper extremity prosthetics in recent years. Yet, the goal of independent digital control remains elusive, given the limitations of the human-prosthesis interface. Surface myoelectric signals must be detectable to power these prosthetics, and patients with partial or total hand amputations usually lack the requisite number of functioning, detectable muscles.

The Rules for Opioid Prescribing are Critical and Confusing

Eeric Truumees, MD

Over the last few years, there has been a steady increase in the number of articles in the medical press and academic journals on the opioid crisis. Some of them relate to changes in the federal response, but often state-wide, pharmacy company, and hospital system initiatives are presented.